EXTON, PA / ACCESSWIRE / December 20, 2019 / First Resource Bank (OTCQX:FRSB) announced that during its regular Board of Directors meeting held on December 18, 2019, the Board unanimously voted to promote Executive Vice President and Chief Financial Officer, Lauren Ranalli, to the position of President and Chief Financial Officer. This appointment comes at the recommendation of longtime business partner and First Resource Bank Chief Executive Officer, Glenn Marshall. In this elevated role, effective January 1, 2020, Ranalli will oversee daily management of the Bank in addition to her current duties as CFO.

"Lauren has been a cornerstone of the Bank's foundation and a trusted business partner since the Bank's formation nearly 15 years ago. I am so pleased to announce her appointment by our Board of Directors to President of First Resource Bank. Lauren's expanding leadership within the Bank will immensely benefit our customers, shareholders and employees, as she evolves our service delivery platform which will be a key driver in the Bank's future growth," commented Marshall.

"After co-founding the Bank with Glenn and serving as CFO for 15 years, I am confident we have built a solid foundation with a solid team. I am thrilled to take on this expanded role at First Resource Bank and to continue playing an integral part in the Bank's future growth and success," said Ranalli. "Having earned the reputation as the "Best Bank" in our market area, we have a lot of opportunity to continue to thrive in southeastern Pennsylvania and I'm honored to lead our team as President as we make the most of these opportunities."

About First Resource Bank

About First Resource Bank First Resource Bank is a locally owned and operated Pennsylvania state-chartered bank, serving the banking needs of businesses, professionals and individuals in the Delaware Valley. The Bank offers a full range of deposit and credit services with a high level of personalized service. First Resource Bank also offers a broad range of traditional financial services and products, competitively priced and delivered in a responsive manner to small businesses, professionals and residents in the local market. For additional information visit our website at www.firstresourcebank.com. Member FDIC.

This press release contains statements that are not of historical facts and may pertain to future operating results or events or management's expectations regarding those results or events. These are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. These forward-looking statements may include, but are not limited to, statements about our plans, objectives, expectations and intentions and other statements contained in this press release that are not historical facts. When used in this press release, the words "expects", "anticipates", "intends", "plans", "believes", "seeks", "estimates", or words of similar meaning, or future or conditional verbs, such as "will", "would", "should", "could", or "may" are generally intended to identify forward-looking statements. These forward-looking statements are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are either beyond our control or not reasonably capable of predicting at this time. In addition, these forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Actual results may differ materially from the results discussed in these forward-looking statements. Readers of this press release are accordingly cautioned not to place undue reliance on forward-looking statements. First Resource Bank disclaims any intent or obligation to update publicly any of the forward-looking statements herein, whether in response to new information, future events or otherwise.

Media Contact:

Glenn Marshall, CEO
610-561-6013

SOURCE: First Resource Bank

ReleaseID: 570879

Israeli Military Robotics Pioneer to Celebrate its Successful Listing on the TSX Venture Exchange

TEL AVIV, ISRAEL / ACCESSWIRE / December 20, 2019 / A2Z Technologies Canada Corp. ("A2Z" or the "Company") (TSXV:AZ) an advanced military robotics and technology company, announced today that CEO Bentsur Joseph and the Company staff will ring the opening bell of the Toronto Stock Exchange on Monday, December 23rd, in celebration of the commencement of trading of the Company's stock on the TSX Venture Exchange.

The event, to be broadcasted on BNN Canada at the TSXV open at 9:30 AM EST, will be preceded by remarks from the Company's CEO, Mr. Bentsur Joseph, Israeli Representative of the Toronto Stock Exchange, Mr. Yossi Boker, and the business attaché of the Canadian Embassy.

The celebratory event will take place in Tel Aviv and the program schedule will be as stated below. The Company will be showcasing several of its UGVs (Unmanned Ground Vehicles) for military and firefighting use, with an unusual special twist to be kept under wraps until the event.

"What an incredible journey this has been" said Bentsur Joseph, CEO of A2Z. "We want to express tremendous gratitude and appreciation to our investors, shareholders, and of course, our employees and the entire team for all the hard work they have put in. We are grateful for their ongoing support and for joining with us as we head towards a very exciting future."

BUSINESS OF A2Z

A2Z Technologies Canada Corp. is an innovative technology company based out of Israel, specializing in military technology and expanding into the civilian markets. A2Z has been operating for over 20 years and has a client base with 75 recurring clients, including the Israel Defense Forces, Security Forces, and Ministry of Defence among others. A2Z plans to leverage their cash flow-generating core-business to expand into the civilian robotics and automobile markets.

According to Zion Market Research, the Military Robotics space is expected to reach $53.93B by 2027 for a projected CAGR of 13.5%.(Summary of Report).

Highlights:

Core Business: A2Z's line of products include unmanned remote-controlled vehicles of various sizes designed for intricate bomb disposal, counter terrorism, and fire fighting, as well as energy storage power packs/generators. A2Z also provides maintenance services to both external and in-house complex electronic systems and products to over 75 clients.

A2Z has been an Israel Ministry of Defense contractor for over 30 years and a significant portion of it's business is long-term service contracts.

Expansion into Civilian Market: To drive growth, A2Z plans to adapt its military technologies for the much larger civilian markets. One patent-pending product is a capsule (FTICS) that prevents vehicle fires resulting from collisions. A2Z has also been granted a patent for a smart vehicle cover device that protects automobiles from the elements while the vehicle is parked and is stowed away safely in the vehicle's bumper when not in use.

Fuel Tank Intelligent Containment System (FTICS): In the event of a collision, the FTICS system installed into the fuel tank prevents the ignition of fuel, thereby mitigating the spread of fire and explosion, minimizing risk to human life and property damage.According to the NFPA, from 2014 to 2016, an estimated 171,500 highway vehicle fires occurred in the United States, resulting in an annual average of 345 deaths, 1,300 injuries, and $1.1 billion in property loss annually.

Management: CEO Bentsur Joseph's previous venture, Comfy Interactive, was acquired by Shamrock Holdings, the family investment firm founded by Roy Disney. Previously, Bentsur Joseph was the chairman of Elad Hotels whose holdings include the Plaza Hotel in New York City.

Bentsur Joseph has a ~64% ownership stake in the business with 30,000,000 shares subject to an escrow agreement.

For more information regarding A2Z, please visit the Company's website at www.a2zas.com.

A2Z Technologies Bell Ringing Ceremony

Stutko Events, Shetrit Street 2, Tel Aviv
Event to be broadcast via Bloomberg Canada and other Media
Program Schedule:
1:30 PM – Gathering and Networking
2:00 PM – Lunch
3:00 PM – TSX Bell Ringing Ceremony
3:15 PM – Menorah Lighting, Second night of Chanukah

On Behalf of the Board of Directors of A2Z Technologies Canada Corp.

Bentsur Joseph
Director and CEO

Investor Relations:

Arlen Hansen
Kin Communications
1-866-684-6730
az@kincommunications.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to inherent risks and uncertainties. All statements within this news release, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those described in forward-looking statements. Factors that could cause actual results to differ materially from those described in forward-looking statements include fluctuations in market prices, including metal prices, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under applicable laws.

ABOUT A2Z TECHNOLOGIES CANADA CORP.

A2Z's principal activities have been the application of advanced engineering capabilities to the military/security markets as well as the adaptation of certain military products for the civilian market. A2Z's line of products include unmanned remote-controlled vehicles of various sizes designed for intricate bomb disposal, counter terrorism, and fire fighting, as well as energy storage power packs/generators. A2Z also provides maintenance services to both external and in-house complex electronic systems and products to over 75 clients.

For future growth, A2Z is implementing a two-pronged approach: (1) continuing to adapt its current military products for civilian use, and; (2) developing two innovative products for the automotive market. One patent-pending product is a capsule that can be placed in a fuel tank to prevent gas tank inflammation upon collision. An additional product under development for which a patent has been granted is a smart vehicle cover device that will protect automobiles from the elements while the vehicle is parked and will prevent snow from building up on the vehicle.

For more information regarding A2Z, please visit the Company's website at www.a2zas.com.

SOURCE: A2Z Technologies Canada Corp.

ReleaseID: 570898

Announces Frac on Its A35 #1H Well and Finishes Drilling the A25 #2

PLANO, TX / ACCESSWIRE / December 20, 2019 / Torchlight Energy Resources, Inc. (NASDAQ:TRCH) ("Torchlight" or the "Company"), today announced that the completion of the Cactus A35 #1H lateral has been scheduled and will be delivered this week. The planned frac is an attempt to break through the dual porosity system and expand pore access in the oil window of the Pennsylvania Silt Zone encountered during drilling. The frac is designed to be a single stage and will deliver 9,500 Barrels of water with 3,000 pounds of sand per foot in a five cluster interval. A single-stage frac is being employed to show the potential for commercial oil production from the target zone. Results will be used to develop a production profile and assumptions for extended laterals with multi-stage frac deployment. The flowback of frac fluid will commence immediately following the procedure.

The Company has also finished the drilling phase of the Founders A25 #2 well and is currently running a full suite of drilling logs and sidewall cores. The A25 #2 well reached a total depth of ~7,250 feet and is currently classified as open hole, pending completion. Upon collection and analysis of gathered scientific data, a frac will be engineered to target one or more of formations encountered with expected delivery early in the new year.

"We are pleased with all aspects of our current operational endeavors," stated John Brda, Torchlight's CEO. "The single stage-frac being deployed on the A-35 1H is designed to validate our thesis for commercial liquid hydrocarbon production from the Pennsylvania Silt pay-zone. Results will allow for multi-stage completion and production modelling, a crucial and impactful component to the overall Orogrande basin profile and our ongoing marketing efforts. We are also optimistic about our progress in developing the vertical potential for this asset. Based on the success in the Helms and Barnett/Woodford sections to the east of us we expect to expand the project's unconventional potential and further deepen the value of this play."

About Torchlight Energy

Torchlight Energy Resources, Inc. (NASDAQ:TRCH), based in Plano, Texas, is a high growth oil and gas Exploration and Production (E&P) company with a primary focus on acquisition and development of highly profitable domestic oil fields. The company has assets focused in West and Central Texas where their targets are established plays such as the Permian Basin. For additional information on the Company, please visit www.torchlightenergy.com.

Forward Looking Statement

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. Such forward-looking statements involve known and unknown risks and uncertainties, including risks associated with the Company's ability to obtain additional capital in the future to fund planned expansion, the demand for oil and natural gas, general economic factors, competition in the industry and other factors that could cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. The Company is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

Investor Relations Contact
Derek Gradwell
Investor Relations Consultant
Phone: 512-270-6990
Email: ir@torchlightenergy.com

SOURCE: Torchlight Energy Resources, Inc.

ReleaseID: 570894

Deal comprises parts for post-warranty repairs of popular Idea and Think computer brands

LAWRENCEVILLE, GA / ACCESSWIRE / December 20, 2019 / Encompass Supply Chain Solutions, Inc., a leading provider of replacement parts and supply chain services for a diverse range of product brands, today announced it will continue distributing parts for Lenovo's Idea and Think computer brands until at least 2022 under a recent contract extension.

In addition to parts supply, the three-year agreement also calls for Encompass to continue providing contact center support and hosting a customized ecommerce web portal to help customers quickly find Lenovo parts: lenovo.encompass.com. Encompass supplies end users, authorized service centers, retailers and third-party administrators with genuine Lenovo parts for out-of-warranty repairs; Lenovo retains management of in-warranty parts distribution.

Encompass was first tapped in 2015 to manage parts supply for non-warranty repairs of Lenovo Idea tablets, laptops and desktops. Based on the success of that program, Lenovo expanded the agreement in 2016 to include the Think brand.

"We are very gratified to have earned Lenovo's confidence and trust to continue supporting their flagship brands," said Eddie Cafferty, director of Encompass' Computer Vertical Business Development.

Cafferty said Encompass' performance on the Lenovo program is closely tracked by specific metrics the supplier must attain, such as order fill rates, same day shipping, on-time delivery and order accuracy. Encompass provides Lenovo regular comprehensive reporting on performance metrics, as well as data on inventory levels and customer transaction history.

Lenovo North America Parts Sales Director Rick Julien said Encompass has so far achieved its performance obligations and customer service responsibilities.

"Lenovo has been extremely pleased with Encompass and their support of both our consumer and commercial customers," said Julien. "We understand how vital computing devices are to the everyday lives of users and are fully committed to standing behind our products after the sale. As such, it's critical for us to have a partner that can be relied upon to represent our brand and ensure fast access to Lenovo Genuine Parts to keep their Lenovo products functioning properly."

About Lenovo

Lenovo is a US$39 billion personal technology company, the largest PC company in the world, serving customers in more than 160 countries. Dedicated to building exceptionally engineered PCs and mobile internet devices, Lenovo's business is built on product innovation, a highly-efficient global supply chain and strong strategic execution. Formed by Lenovo Group's acquisition of the former IBM Personal Computing Division, the company develops, manufactures and markets reliable, high-quality, secure and easy-to-use technology products and services. Its product lines include legendary Think-branded commercial PCs and Idea-branded consumer PCs, as well as servers, workstations, and a family of mobile internet devices, including tablets and smartphones. As a global Fortune 500 company, Lenovo has major research centers in Yamato, Japan; Beijing, Shanghai and Shenzhen, China; Sao Paulo, Brazil, and Raleigh, North Carolina. For more information see www.lenovo.com.

About Encompass Supply Chain Solutions, Inc.

Formed in 1953, Encompass is one of the country's largest suppliers of repair parts and accessories for products throughout the home. Encompass also offers complete parts supply chain management, 3PL, depot repair and reverse logistics service. In addition to consumers, we support an array of B2B customers, including manufacturers, multi-family property management, warranty providers, service networks, independent dealers and retailers.

For more information, please visit solutions.encompass.com and follow us on LinkedIn, Facebook and Twitter.

CONTACT:

Kristin Hurst
Director of Marketing & Communications
Ph: 954.474.0325
khurst@encompass.com

SOURCE: Encompass Supply Chain Solutions, Inc.

ReleaseID: 570908

NEW YORK, NY / ACCESSWIRE / December 20, 2019 / MXC Exchange is brewing a quiet change.

In recent days it seems that MXC Exchange is in line with the bearish momentum and keeps a low profile, but, in real, its pace has not slowed down at all.

The Margin Trading feature that had been tested for many times was launched on November 7. About a month ago, MXC Exchange announced on the official website that it will officially launch the public beta of margin trading at 14:00 (UTC+8), November 7th to provide users with leverage services.

Only five days after the launching of margin trading feature, MXC Exchange, together with Cobo and other 6 institutions jointly launched the Loop Alliance. It solved the problems of transaction congestion, delays and excessive fees in the inter-agency clearing and settlement blockchain network. Transfer between agencies in Loop Alliance is free of delay and service fee. In addition , On December 1, MXC Exchange announced that in November it repurchased and burnt a total of 7,309,567.36 MX. And on December 3, the ETH adding in "PoS Stakings" was announced.

The business of MXC Exchange seems to be rolling out faster than before.

From the launching of the margin trading to joining the Loop Alliance to solve the problem of slow and expensive transfers; from the low-profile repurchase of local token to adding major cryptocurrency in "PoS Stakings" … MXC Exchange is incorporating the previously unexplored businesses into its strategic layout, trying hard to enrich its ecosystem . Some people have commented that today's MXC Exchange seems to be more robust than several month ago when dauntless effort was made to strive forward. This shall be attributed to the down-to-earth efforts of MXC Exchange around the business and product line.

However, data comparison and scientific method are required to decide whether MXC Exchange is really devoted for the margin product. This article will scientifically evaluate the margin trading of MXC Exchange and analyze its comprehensive strength in detail.

Margin Trading Comparison in a Chart

At present, there are many exchanges that support margin trading, so we has selected four major exchanges for comparison. As a digital-currency derivative derived from traditional finance, margin trading can be analyzed in the following five aspects: number of supported currency, funding rate, loan rate, leverage times, and margin mode.

All data of the four exchanges on margin trading is shown below

Please note the following four points:

1. The supported currencies refers to tradable currencies, not the number of trading pairs.

2. The initial funding rate is adopted among the four exchanges, because, though some may provide tiered funding rate system, it is not suitable for ordinary retail investors as it often requires large transaction volume to get the discount rate.

3. In terms of loan rate, the loan rate for USDT is taken for reference because even in a same exchange, different crypto has different loan rate. For example, the loan rate for USDT on MXC Exchange is 0.03%, while for BTC, it is 0.1%.

4. The data in this article is real data. The evaluation analysis is subjective opinion. If you have different views, discussion is welcomed.

Therefore, we will evaluate the margin trading of MXC Exchange from the five perspectives.

I. Number of Supported Cryptourrencies

According to the official website of MXC Exchange, it added the RVN / USDT trading pair on margin trading on December 9th and the loan for RVN is available with an interest rate of 0.1%. It is the 45th token that MXC Exchange supported in margin trading. As a platform where the margin trading has just been launched for a month, MXC Exchange do make an accomplishment.

Therefore, in terms of quantity, the score shall be:

Binance: ★★★★ ☆

Huobi: ★★★★ ☆

OKEx: ★★★ ☆

MXC Exchange: ★★★★★

II. Service Fee Rate:

As one of the key points of comparison, funding rate is often easily overlooked by traders, but it is an important part for comparison.

The service fee rate for margin trading on MXC Exchange is the same as that of the spot trading. That is 0.2%. In other word, $2 will be charged for every $1000 transaction, and of course, the loan is included. This fee rate is generally adopted by many exchanges.

After comparing with other exchanges, the service fee rate of MXC Exchange is not favorable.

In terms of fee rate, Binance is the lowest, with both Maker and Taker reaching 0.1%. In addition, with BNB payment, the fee can also be deducted 25% off. OKEx is followed by Maker0.1% and Taker0.15%. However, in term of tiered fee rate, it is necessary to hold a certain amount of OKB to enjoy discount, so there is no advantage compared to Binance. Although the fee rate on MXC Exchange is 0.2%, it supports MX token payment with a discount of 20%. It is 0.16% after discount. Finally, the fee rate of Huobi is also 0.2%. Users who have to hold a certain amount of HT to enjoy its tired fee rate preference.

In the perspective of ordinary retail users, the score for the exchanges shall be:

Binance: ★★★★★

Huobi: ★★★☆

OKEx: ★★★★☆

MXC Exchange: ★★★★

III. Loan Rate

As to the margin trading, the loan rate is definitely a field that every exchange will compete against. However, because different currencies have different loan rates on the same exchange, the loan rate of USDT among the exchanges are taken for comparison.

As shown in the table above, except for Binance's hourly rate, the mainstream loan rates in the market are daily rates.

Binance's daily interest rate is about 0.0275%, the lowest in the market, and 0.03% of MXC Exchange is close behind. OKEx and Huobi's 0.098% are higher than the previous two. However, holders of HT can enjoy tired loan rate , where high as 65% discount can be offered for holders of more than 5000 HT.

In terms of loan rate, the scores are:

Binance: ★★★★★

Huobi: ★★★★

OKEx: ★★★★

MXC Exchange: ★★★★☆

IV. Leverage Multiples

Margin trading is not the same as a futures contract. Futures contracts are a type of agreement, with multiples ranging from 10 to 100; margin trading is more like spot trading, with multiples ranging from 2 to 5 times.

The leverage multiples of margin trading on MXC Exchange is the same as the prevailing leverage multiples on the market, which are basically 2-5 times. OKEx, which has a long operating time for margins and futures, is more aggressive than other trading platforms, and the leverage multiple is higher.

Although it increases some of the risks, it also provides users with greater choice.

The scores on this perspective shall be:

Binance: ★★★★

Huobi: ★★★★

OKEx: ★★★★☆

MXC Exchange: ★★★★

V. Margin Mode

In contract trading, cross margin and isolated margin are often mentioned. In terms of cross margin, the margin is shared between open positions. When needed, a position will draw more margin from the total account balance to avoid liquidation. In terms of isolated margin, the margin assigned to a position is restricted to a certain amount. If the margin falls below the Maintenance Margin level, the position is liquidated. However, you can add and remove margin at will under this method.

The margin mode for margin trading is similar. According to the official announcement and data, MXC Exchange margin trading now only supports cross margin. Compared to Huobi where both cross and isolated margin are available, there is still room for improvement.

In this part, the score shall be:

Binance: ★★★★

Huobi: ★★★★★

OKEx: ★★★★

MXC Exchange: ★★★★

Comprehensive Analysis

As the main character of the article, the margin trading on MXC Exchange is not inferior to that of the long-established trading platform in data analysis. And do remember that its margin trading module is only launched for one month. High-efficiency and strong execution are the advantages of MXC Exchange. In addition, it pays more attention on qualities instead of quantity and speed.

MXC Exchange is steadily walking on a path of excellence where it delivers determination to get out of the bearish market trend.

Organization: MXC PRO FOUNDATION LTD
Email: business@mxc.com

Media Relation
800-2365-8932
Website: www.mxc.com

SOURCE: MXC PRO FOUNDATION LTD

ReleaseID: 570923

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO.

DIDCOT, UK / ACCESSWIRE / December 20, 2019 /  Altus Strategies Plc (AIM:ALS)(TSX-V:ALTS), the Africa focused project and royalty generator, announces that it has conditionally raised C$4,169,592 / £2,409,098 (before expenses) by way of a non-brokered private placement offering of 46,328,802 ordinary shares ("Ordinary Shares") at an issue price of C$0.09 / £0.052 per share with existing and new institutional and private investors (the "Offering"). The Offering included participation by certain directors and Persons Discharging Managerial Responsibilities ("PDMR"), subscribing for 7,276,239 new Ordinary Shares in aggregate. Approximately C$1,260,000 / £728,000 of the Offering is conditional upon the approval of TSX Venture Exchange ("TSXV").

Steve Poulton, Chief Executive of Altus, commented:

"We are delighted by the very positive response from new and existing institutional and private investors to our Offering and we welcome all of our new investors to the Company.

"Separate to closing the Offering, excellent progress is being made on completing the documentation to call a general meeting in respect of the strategic investment by La Mancha, whereby La Mancha will invest C$11.2 million / £6.5 million at C$0.09 per share, which is conditional upon Altus shareholder approval.

"Taking the Offering and the La Mancha investment together, Altus is positioned for a transformative 2020. We are looking forward to accelerating our project and royalty generation activities, as well as securing further value accretive opportunities."

Details of the Offering

The Offering is conditional, amongst other things, on the admission of the new Ordinary Shares to trading on the AIM market ("AIM") of the London Stock Exchange. Application has been made to the London Stock Exchange for 32,328,802 new Ordinary Shares to trading on AIM and it is expected that the First Admission and dealings in these new Ordinary Shares will commence on AIM at 8.00 a.m. on, or around, 23 December 2019 ("First Admission").

DELPHI Unternehmensberatung Aktiengesellschaft ("Delphi") of Heidelberg Germany is a subscriber to the Offering. Approximately C$1,260,000 / £728,000 of the Delphi subscription remains conditional upon the TSXV approving Delphi owning more than 10.0% of the enlarged share capital of the Company, which pursuant to TSXV policies, would cause Delphi to become an insider of Altus holding approximately 15.61% of the enlarged share capital. Upon receipt of TSXV approval, application will be made to the London Stock Exchange by the Company for a further 14,000,000 new Ordinary Shares ("Second Admission") to be admitted to trading on AIM. A further announcement will be made by the Company in due course in respect of the Second Admission.

All Ordinary Shares issued under the Offering are subject to a hold period in Canada of four months from the Closing Date expiring on 20 April 2020 for the First Admission and four months from the date of the Second Admission as applicable and pursuant to Canadian securities laws. No finder fees or other commissions are being paid in respect of the Offering.

The new Ordinary Shares will represent approximately 15.38% of the Company's enlarged issued share capital on First Admission and 20.66% of the Company's then enlarged issued share capital on Second Admission.

Details of Director and PDMR subscriptions

Details of Director and PDMR subscriptions in the Offering are outlined in the table below:

Director

Position

New Ordinary Shares being subscribed

Shareholding following First Admission

% holding following First Admission

% holding following Second Admission

David Netherway

Chairman

1,456,275

12,206,875

5.81%

5.44%

Steven Poulton

Chief Executive

2,675,481

27,825,481

13.24%

12.41%

Matthew Grainger

Executive Director

1,280,328

10,427,828

4.96%

4.65%

Robert Milroy

Non-Executive Director

1,362,179

1,937,179

0.92%

0.86%

Charlie Douglas-Hamilton

New Business

425,053

480,709

0.23%

0.21%

William Slater

VP Exploration

76,923

1,080,523

0.51%

0.48%

Related Party Transaction

As David Netherway, Steven Poulton, Matthew Grainger and Robert Milroy are directors of the Company and Charlie Douglas-Hamilton and William Slater are directors of a subsidiary of the Company, their subscriptions constitute a related party transaction pursuant to AIM Rule 13 ("Related Party Transactions"). Michael Winn, being the independent director of the Company, having consulted SP Angel Corporate Finance LLP, considers that the terms of the Related Party Transactions were fair and reasonable insofar as the shareholders of the Company were concerned.

Use of Proceeds

The planned use of the proceeds of the Offering is for exploration and royalty generation activities on the Company's licences in Africa, settlement of accrued expenses (including outstanding director fees and salaries) and for general corporate purposes.

Total Voting Rights

Following First Admission, there will be a total of 210,228,461 Ordinary Shares in issue, none of which are held in treasury. Shareholders should use that number as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Following Second Admission, there will be a total of 224,228,461 Ordinary Shares in issue, none of which are held in treasury.

No offer or solicitation

This Announcement is for information purposes only and does not constitute an invitation to any person to purchase or subscribe for Shares or any other securities or engage in any form of investment activity. This Announcement is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part, in, into or within the United States of America its territories and possessions, any state of the United States or the District of Columbia (collectively, the "United States"), Australia, Japan, New Zealand or the Republic of South Africa or any other jurisdiction where to do so might constitute a violation of the relevant laws or regulations of such jurisdiction. This Announcement is also being released in Canada as part of the Company' continuous disclosure record.

This Announcement is directed only at persons in member states of the European Economic Area ("EEA") who are qualified investors within the meaning of Article 2(e) of Regulation (EU) 2017/1129, as amended from time to time (the "Prospectus Regulation"), ("Qualified Investors"). In addition, in the United Kingdom, this Announcement and any offer if made subsequently is directed only at Qualified Investors, who are also (i) persons who have professional experience in matters relating to investments falling within the definition of "Investment Professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), (ii) high net worth entities falling within Article 49(2) of the Order or (iii) other persons to whom it may lawfully be communicated (all such persons together being referred to as "Relevant Persons"). This Announcement must not be acted on or relied on (i) in any member state of the European Economic Area, by any person who is not a Qualified Investor (ii) in the UK, by any person who is not a Relevant Person.

For further information you are invited to visit the Company's website www.altus-strategies.com or contact:

Altus Strategies Plc

Steven Poulton, Chief Executive
Tel: +44 (0) 1235 511 767
E: info@altus-strategies.com

SP Angel (Nominated Adviser)
Richard Morrison / Soltan Tagiev
Tel: +44 (0) 20 3470 0470

SP Angel (Broker)
Abigail Wayne / Richard Parlons
Tel: +44 (0) 20 3470 0471

Blytheweigh (Financial PR)
Tim Blythe / Camilla Horsfall
Tel: +44 (0) 20 7138 3204

About Altus Strategies Plc

Altus is a London (AIM: ALS) and Toronto (TSX-V: ALTS) listed project and royalty generator in the mining sector with a focus on Africa. Our team creates value by making mineral discoveries across multiple licences. We enter joint ventures with respected groups and our partners earn interest in these discoveries by advancing them toward production. Project milestone payments we receive are reinvested to extend our portfolio, accelerating our growth. The portfolio model reduces risk as our interests are diversified by commodity and by country. The royalties generated from our portfolio of projects are designed to yield sustainable long-term income. We engage constructively with all our stakeholders, working diligently to minimise our environmental impact and to promote positive economic and social outcomes in the communities where we operate.

Cautionary Note Regarding Forward-Looking Statements

Certain information included in this Announcement, including information relating to future financial or operating performance and other statements that express the expectations of the Directors or estimates of future performance constitute "forward-looking statements". These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include without limitation the completion of planned expenditures, the ability to complete exploration programmes on schedule and the success of exploration programmes. Readers are cautioned not to place undue reliance on the forward-looking information, which speak only as of the date of this Announcement and the forward-looking statements contained in this announcement are expressly qualified in their entirety by this cautionary statement.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. The forward-looking statements contained in this Announcement are made as at the date hereof and the Company assumes no obligation to publicly update or revise any forward-looking information or any forward-looking statements contained in any other announcements whether as a result of new information, future events or otherwise, except as required under applicable law or regulations.

Neither the TSX Venture Exchange nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this release.

Disclaimer

SP Angel Corporate Finance LLP, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for the Company and no one else (including the recipients of this announcement) as nominated adviser and will not be responsible to anyone other than the Company for providing the protections afforded to customers of SP Angel Corporate Finance LLP or for advising any other person in relation to the matters described in this announcement.

Market Abuse Regulation Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR") until the release of this announcement. In addition, market soundings (as defined in MAR) were taken in respect of the placing and other matters contained in this announcement, with the result that certain persons became aware of such inside information, as permitted by MAR. That inside information is set out in this announcement and is now considered to be in the public domain. Therefore, upon the publication of this announcement, those persons that received is inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

1

Details of the relevant person / person closely associated

a)

Name

1. Steve Poulton

2. David Netherway

3. Matthew Grainger

4. Robert Milroy

5. Charlie Douglas-Hamilton

6. William Slater

2

Reason for the notification

a)

Position/status

1. CEO

2. Chairman

3. Executive Director

4. Non-executive Director

5. PDMR (non-board)

6. PDMR (non-board)

b)

Initial notification/ Amendment

INITIAL NOTIFICATION

3

Details of the issuer

a)

Name

ALTUS STRATEGIES PLC

b)

LEI

213800IP93D9LMFIUA28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii each type of transaction; (iii each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

SHARE

Identification code

ISIN: GBOOBYT26M80

b)

Nature of the transaction

PURCHASE OF ORDINARY SHARES

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1.

£0.052

2,675,481

2.

£0.052

1,456,275

3.

£0.052

1,280,328

4.

£0.052

1,362,179

5.

£0.052

425,053

6.

£0.052

76,923

d)

Aggregated information

Aggregated volume

7,276,239

Price

£0.052

e)

Date of the transaction

19 December 2019

f)

Place of the transaction

Off-market

SOURCE: Altus Strategies PLC

ReleaseID: 570884

BALA CYNWYD, PA / ACCESSWIRE / December 20, 2019 / Law office of Brodsky & Smith, LLC reminds investors of the deadline to file regarding claims against Merit Medical Systems, Inc. ("Merit Medical" or the "Company") (Nasdaq:MMSI) for possible breaches of Federal Securities law.

The Class Period commences on February 26, 2019, when Merit Medical reported fourth quarter 2018 and fiscal year 2018 results and established financial guidance for 2019, including core revenue growth of 8%-10%.

According to the filed complaint, Merit Medical is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. During 2018, Merit Medical acquired three companies. Specifically, in February 2018, the Company completed the acquisition of Becton, Dickinson and Company and on November 13, 2018, the Company completed the acquisition of Cianna Medical, Inc. ("Cianna"), which makes products for the treatment of breast cancer, for up to $200 million, making it Merit Medical's largest-ever acquisition. Thereafter, in December 2018, the Company completed its acquisition of Vascular Insights, LLC ("Vascular Insights"), and acquired its ClariVein product, for up to $60 million.

On October 30, 2019, after the market closed, Merit Medical issued a press release announcing its third quarter 2019 financial results, reporting non-GAAP EPS of $0.28, well below consensus estimates of $0.45, reducing fiscal year 2019 guidance, and completely withdrawing fiscal year 2020 guidance. Following this news, the Company's stock price declined more than 29%, from a close of $29.11 per share on October 30, 2019 to a close of $20.66 per share on October 31, 2019.

The filed complaint alleges that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (a) the integrations of Cianna and Vascular Insights, including their products, salespeople, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights' products which, as late as July 2019, had zero orders during fiscal year 2019; and (c) in light of the foregoing, the Company's reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis.

If you purchased shares of Merit Medical between February 26, 2019 and October 30, 2019 and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. The deadline for filing is February 3, 2020. You may contact Marc Ackerman, Esquire or Jordan Schatz, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by visiting http://www.brodskysmith.com/?post_type=cases&p=13407&preview=true, or by calling toll free 877-534-2590.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.

SOURCE: Brodsky & Smith, LLC

ReleaseID: 570846

Sphingotec reports study data demonstrating that its proprietary renal function biomarker penKid(R) (Proenkephalin) predicts acute kidney injury (AKI), multi-organ failure and mortality in sepsis patients presenting to the emergency department (ED).
High penKid(R) plasma levels identified all ED patients with hidden AKI and AKI at admission and reflected worsening of kidney function.
penKid(R) point-of-care (POC) implementation in EDs could eliminate current limitations of AKI prediction in septic patients allowing physicians to adjust treatment and therapy monitoring of patients with suspected AKI.
An automated CE-marked IVD penKid(R) assay running on sphingotec's POC platform Nexus IB10 will be launched in Q1 2020.

HENNIGSDORF and BERLIN, GERMANY / ACCESSWIRE / December 20, 2019 / Diagnostics company SphingoTec GmbH ("sphingotec", Hennigsdorf Germany) today reported on the publication of novel study results of its proprietary kidney function biomarker penKid(R) in BMC Emergency Medicine1. The data from a prospective study enrolling 588 septic patients demonstrate that penKid(R) accurately predicted acute kidney injury (AKI), multiorgan failure (MOF) and mortality in unselected sepsis patients at presentation to the emergency department (ED). Furthermore, increasing penKid(R) blood levels indicated worsening kidney function.

While organ dysfunction is a hallmark of sepsis, the renal system is being particularly susceptible. One in two patients with septic shock develop AKI and are at increased risk of both severe morbidity and higher mortality. In the current study, the admission levels of penKid(R) and serum creatinine (SCr) were corelated with patient outcomes. SCr is the current diagnostic standard and is used to calculate the estimated glomerular filtration rate (eGFR), a surrogate parameter quantifying kidney function. In the study, elevated penKid(R) blood levels at admission predicted all septic patients who developed AKI. Furthermore, high penKid(R) levels independently from eGFR, identified patients with subclinical AKI at ED admission, who could not be identified by SCr values. penKid(R) also predicted multiorgan failure and 28-day mortality.

Previously published clinical data from patients with sepsis admitted to intensive care units (ICUs) have provided evidence, that elevated blood levels of penKid(R) at admission predict AKI, worsening kidney function, organ failure and mortality independently from inflammation and other co-morbidities2. The new results demonstrate that penKid(R) can also identify AKI patients in a routine ED setting, in which therapy decision making is currently delayed due to the fact that eGFR assessment requires serial measurements2 and creatinine metabolism is affected by inflammation, fluid overload and the use of nephrotoxic agents3-4. Based on the study results, penKid(R) is a reliable marker for the detection and monitoring of subclinical AKI.

"These study results demonstrate for the first time that penKid(R) provides physicians at the emergency department with urgently needed information, which is complementary to the current diagnostic toolbox and enables the detection of AKI, particularly in patients with hidden AKI risk," said Dr. Andreas Bergmann, founder and CEO of sphingotec. "To support timely treatment decisions that are likely to improve outcomes in critical care patient, we will launch in Q1-2020 a fully automated CE-IVD-marked point-of-care penKid(R) assay on the established Nexus IB10 platform."

Rosenqvist, M. (2019): Proenkephalin A 119-159 (penKid) – a novel biomarker for acute kidney injury in sepsis: an observational study, BMC Emerg Med. doi: 10.1186/s12873-019-0283-9
Caironi P, et al. (2018): Circulating Proenkephalin, acute kidney injury, and its improvement in patients with severe Sepsis or shock. Clin Chem. doi:10.1373/clinchem.2018.288068
Moledina DG, et al. (2018): Phenotyping of acute kidney injury: beyond serum Creatinine. Semin Nephrol. doi: 10.1016/j.semnephrol.2017.09.002.
Ronco C. (2016): Acute kidney injury: from clinical to molecular diagnosis. Critical Care. Doi: 10.1186/s13054-016-1373-7.

About sphingotec 
 SphingoTec GmbH ("sphingotec"; Hennigsdorf near Berlin, Germany) develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary biomarkers for the diagnosis, prediction and monitoring of acute medical conditions, such as sepsis, acute heart failure, circulatory shock, and acute kidney injury in order to support patient management and provide guidance for treatment strategies. sphingotec's proprietary biomarker portfolio includes bioactive adrenomedullin (bio-ADM(R)), a unique biomarker for real-time assessment of endothelial function in conditions like sepsis or congestive heart failure, Proenkephalin (penKid(R)), a unique biomarker for real-time assessment of kidney function, and Dipeptidyl Peptidase 3 (DPP3), a unique biomarker for cardio-renal pathway disruptions leading to acute organ dysfunction. In addition, sphingotec develops a portfolio of novel biomarkers, which predict the risks of developing obesity, breast cancer and cardiovascular diseases. IVD tests for sphingotec's proprietary biomarkers are made available as sphingotest(R) microtiterplate tests as well as point-of-care tests on the Nexus IB10 immunoassay platform by sphingotec's subsidiary Nexus Dx Inc. (San Diego, CA, USA) alongside a broad menu of IB10 tests for established biomarkers for acute and critical care.

About penKid(R)
Proenkephalin (penKid(R)) is a unique and proprietary biomarker for real-time assessment of kidney function. penKid(R) is a functional kidney marker that works in plasma, is independent from comorbidities and inflammation and provides timely information about the changing kidney function in critically ill patients. sphingotest(R) penKid(R) is a surrogate marker for the gold standard of glomerular filtration rate (GFR) and indicates two days earlier than the standard-of-care the development of acute kidney injury (AKI) in critically ill patients. These features enable physicians to predict, diagnose and closely monitor worsening and improving kidney function on intensive care units or emergency departments.

About Nexus Dx Inc. and the IB10 Platform
Nexus Dx Inc., a wholly-owned subsidiary of sphingotec, headquartered in San Diego, CA, USA, is a global provider of a near patient testing system and advanced diagnostic solution. The company is improving patient care by providing the medical community with rapid and reliable information at the point of care (POC), delivering patient information when and where it is needed most. The company has invested over $160m to develop and market the IB10 analyzer system which, without the need for sample preparation, automatically separates plasma from whole blood with subsequent reliable and quantitative detection of biomarkers in the plasma by means of antibodies. With a hands-on-time of less than 3 minutes the easy-to-use system provides in only 20 minutes test results for biomarkers that are crucial in the management of critical care patients. The portfolio of IB10 assays includes tests for established critical care parameters such as Procalcitonin, Troponin I, CK-MB, Myoglobin, NT-proBNP, and D-Dimer as well as tests for sphingotec's proprietary biomarkers such as DPP3, an assay for Dipeptidyl Peptidase 3, a unique and proprietary biomarker for cardio-renal pathway disruptions leading to acute organ dysfunction. The IB10 assay for bioactive Adrenomedullin (bio-ADM(R)), a unique and proprietary biomarker for endothelial function and the assay for Proenkephalin (penKid(R)), a unique and proprietary biomarker for real-time assessment of kidney function, will be launched later in 2020. 

Contact 
SphingoTec GmbH
Ruxandra Lenz
Neuendorfstr. 15a
16761 Hennigsdorf
Germany
Tel. +49-3302-20565-34
press@sphingotec.de
www.sphingotec.com

SOURCE: SphingoTec GmbH

ReleaseID: 570922

VANCOUVER, BC / ACCESSWIRE / December 20, 2019 / ZoomAway Travel Inc. (TSXV:ZMA)(OTC PINK:ZMWYF) (the "Company" or "ZMA") www.zoomaway.com, a leader in the hospitality technology sector, is pleased to announce that ZOOMEDOUT has signed its first "Beta" agreement with SpeedVegas© in Las Vegas (www.speedvegas.com).

This award-winning facility, located just 15 minutes from the Las Vegas Strip, is one of the city's most popular adventure hotspots. SpeedVegas brings its customer's exotic car racing fantasies to life on the longest and fastest racetrack in Las Vegas. The company offers multiple experiences in some of the most exotic racing and muscle cars on the planet. Ferrari, Lamborghini, Porsche, just to name a few. In addition, the company boasts a thrill ride of an off-road adventure course that offers an unforgettable thrill of driving and jumping custom built off-road trucks. The company is known for its high level of safety and service and boasts an impressive array of packages and group events that appeal to novices and gear heads alike.

The ZoomedOUT team is in the process of building the SpeedVegas facility from the various tracks to the buildings. The build out will feature and demonstrate some key business drivers that reflect this client's unique offerings. We intend to demonstrate for the client our ability to encourage customers directly from the Strip to the facility via some incredibly innovative and unique advertising tools such as, 3D billboards on the Strip, and blimps flying over the entire city. The team will then demonstrate how "clicking" on the building in the app will open all of the key features of SpeedVegas. From video experiences, social media and customer reviews to retail opportunities including the ability to make purchases from their apparel store.

Sean Schaeffer, CEO of Zoomaway Travel, commented, "This is where the job gets most rewarding. Being able to see the excitement for this product with its actual target market. Being in pre-launch stage means that we need to find the right businesses to approach currently and learn from them exactly what it is that they want in an advertising program. These very early stage successes help us to make sure we're crafting our product with the most appeal which, in turn, will generate dollars from these opportunities. I couldn't be more excited that SpeedVegas is joining us. I suspect this will turn into more and more opportunities."

Greg Schroeder, Chief Operating Officer at Speed Vegas said, "As a member of the Las Vegas Hospitality Community for more than 10 years, I've seen a lot of great ideas, and a lot of change. I can tell you that I believe this product is so unique, and that it has so much potential for not only our business, but for this tourism community in Las Vegas. Our Company spends a substantial amount of our budget marketing electronically through various means. This app is such an interesting proposition in that it not only can drive business directly to us through some really cool advertising in game, but the key is that it keeps people coming back daily to expose us over and over through the various game mechanics like resource collection. I can't wait to see this come to life, we're happy to jump on this ride early and see how ZoomedOUT can help us continue to grow."

For additional information contact: Sean Schaeffer, President, ZoomAway Inc.,

at 775-691-8860 | sean@zoomaway.com or stay up-to-date and sign up for our newsletter.

About Us

ZoomAway, Inc. (Nevada Co.) provides leading hotels, golf resorts, ski resorts, and activity providers with a seamless, scalable, and fully integrated technology platform that allows for the discounted packaging of lodging, ski, golf, activities, and attractions. It seamlessly integrates into client websites, providing their customers with a real-time one-stop shop for all of their travel and recreational needs. Additional information about ZoomAway Inc. can be found at www.zoomaway.com.

Travel Game (Canadian Co.) is a ZoomAway Travel, Inc. subsidiary company dedicated to housing new projects in the digital games. The company's first project is ZoomedOUT which can be seen at zoomedout.io. To receive more detailed, or investor level information, please contact us at sean@zoomaway.com and we will respond with the appropriate documentation depending on your request.

About Zero8 Studios, Inc.

Zero8 Studios, based in Reno, Nevada, specializes in new and innovative games and technology platforms. With a focus on social gaming and almost two decades of experience building
countless game titles, gaming platforms, and various technologies. The Zero8 Studios' team has assisted dozens of AAA publishers, large clientele, manufacturers, and casinos in the design, production, and delivery of their products to players around the world. Additional information can be found at www.zero8studios.com.

Forward-Looking Statements

This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include regulatory actions, market prices, and continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates, and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.

Neither the TSX Venture Exchange nor it's Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed Offering and has neither approved nor disapproved the contents of this press release.

SOURCE: ZoomAway Travel Inc.

ReleaseID: 570892

SHENZHEN, CHINA / ACCESSWIRE / December 20, 2019 / ‘None Formaldehyde, Acetaldehyde, Acrolein, or Diacetyl were detected via a new type of Ultrasonic Vaping device, while in the coil based electronic cigarette with resistance, Formaldehyde can be present up to 2 µg / puff and Acrolein up to 1 µg / puff (at 14 W)' test performed by a French laboratory. This astonishing ultrasonic vaping device, ZIP, is brought by the uprising brand USONICIG.

With innovative UVT (Ultrasonic Vaping Technology) applied to their products, the ultrasonic vaping seems an alternative method of nicotine delivery, while avoiding most of the toxic emission from heating.

Discussion on whether e-cigarettes are even healthy has become a hot topic ever since its firstborn to the world. But none have foreseen since August 2019, as an authority of the federal government, CDC had at first suspected e-cigs for causing many deaths, and then clarified and claimed that the cause of death to vapers are mostly like to be the inappropriate application of Vitamin E.

This behavior of CDC is not only started a discussion but more likely started a storm. Now what we see is tens of thousands of jobs lost in vaping business worldwide; smokers repicked their burning cigarettes along with higher risk in long cancer. People are terrified to discover any other possible method that can relieve them from the anxious of picking up the long-forgotten paper rolls.

USONICIG, as an innovation-oriented brand, although it is very new to world, it is also trying all its best to bring the world a different and hopefully healthier nicotine delivery method for those who are suffered from smoking issues, by keep providing more and more products with conveniences and safety to its user.

Company name：Shenzhen Xiangyuan Technology Co.,Ltd
Website：www.usonicig.com
Contact：Cecily Jin
Email：Cecily@usonicig.com

YouTube: https://www.youtube.com/channel/UCxe5kllc4lbLdyobtiJhcEw
Instagram: https://www.instagram.com/usonicig/
Facebook: https://business.facebook.com/usonicig/
Twitter: https://twitter.com/Usonicig

SOURCE: Shenzhen Xiangyuan Technology Co.,Ltd

ReleaseID: 570921